The Dark Side of “Smart Drugs”: Cognitive Enhancement vs. Clinical Concerns
Abstract The European Union Drugs Agency has emphasized the increasing difficulty in monitoring the drug market due to the emergence…
Abstract The European Union Drugs Agency has emphasized the increasing difficulty in monitoring the drug market due to the emergence…
Abstract Besides classic illegal drugs, numerous designer drugs, also called new psychoactive substances (NPSs), are available on the global drug…
Abstract Novel psychoactive substances (NPS) are popular “club/party” drugs that first attracted attention in the UK in 2009 and remained…
Abstract The Internet has played a major role in the distribution of New Psychoactive Substances (NPS), and crypto markets are…
Abstract Recent designer drugs, also known as “legal highs,” include substituted cathinones (e.g., mephedrone, methylone, and methylenedioxypyrovalerone, often referred to…